Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Northern Trust
Chicago,
Illinois
| $806M | -$23.7M | 78 | 0.14% | Reduced |
|
| 27 |
Perceptive Advisors
New York
| $804M | +$32M | 13 | 14.06% | Increased |
|
| 28 |
EC
EcoR1 Capital
San Francisco,
California
| $766M | +$305M | 12 | 19.37% | Increased |
|
| 29 |
Bank of New York Mellon
New York
| $716M | -$42M | 50 | 0.14% | Reduced |
|
| 30 |
Citadel Advisors
Miami,
Florida
| $708M | +$67.9M | 72 | 0.14% | Increased |
|
| 31 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $700M | -$14M | 3 | 1% | Reduced |
|
| 32 |
Nomura Holdings
Tokyo,
Japan
| $652M | -$5.11M | 6 | 1.63% | Reduced |
|
| 33 |
Invesco
Atlanta,
Georgia
| $648M | -$43.6M | 46 | 0.14% | Reduced |
|
| 34 |
Norges Bank
Oslo,
Norway
| $641M | +$91.4M | 20 | 0.1% | Increased |
|
| 35 |
RG
Redmile Group
San Francisco,
California
| $616M | -$45.4M | 11 | 22.61% | Reduced |
|
| 36 |
Charles Schwab
San Francisco,
California
| $606M | -$1.88M | 55 | 0.14% | Reduced |
|
| 37 |
Paradigm Biocapital Advisors
New York
| $603M | +$109M | 8 | 21.21% | Increased |
|
| 38 |
Millennium Management
New York
| $567M | +$210M | 69 | 0.24% | Increased |
|
| 39 |
Adage Capital Partners
Boston,
Massachusetts
| $564M | +$64.7M | 27 | 1.06% | Increased |
|
| 40 |
ClearBridge Investments
New York
| $542M | +$11.6M | 4 | 0.43% | Increased |
|
| 41 |
NMC
NEA Management Company
Timonium,
Maryland
| $513M | $0 | 6 | 31.83% | Maintained |
|
| 42 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
| $510M | +$29.6M | 3 | 1.18% | Increased |
|
| 43 |
Farallon Capital Management
San Francisco,
California
| $508M | +$245M | 8 | 2.15% | Increased |
|
| 44 |
CC
Casdin Capital
New York
| $469M | +$15.5M | 10 | 34.89% | Increased |
|
| 45 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $453M | +$45.6M | 46 | 0.21% | Increased |
|
| 46 |
Pictet Asset Management
Carouge,
Switzerland
| $451M | +$16.1M | 16 | 0.49% | Increased |
|
| 47 |
UBS Group
Zurich,
Switzerland
| $444M | +$40M | 91 | 0.11% | Increased |
|
| 48 |
Renaissance Technologies
New York
| $439M | -$10.9M | 63 | 0.69% | Reduced |
|
| 49 |
Barclays
London,
United Kingdom
| $436M | -$14.2M | 56 | 0.15% | Reduced |
|
| 50 |
Federated Hermes
Pittsburgh,
Pennsylvania
| $430M | -$89.3M | 24 | 0.99% | Reduced |
|